ArticleAmerican journal of translational research2017

FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

Jin Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.